Experienced in Hepatic Ischemia

Dr. Aradhana M. Venkatesan

Radiology
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Experienced in Hepatic Ischemia
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
OverviewInsuranceLocationsClinical Research

Overview

Aradhana Venkatesan is a Radiologist in Houston, Texas. Dr. Venkatesan is rated as an Experienced provider by MediFind in the treatment of Hepatic Ischemia. Her top areas of expertise are Vaginal Cancer, Renal Cell Carcinoma (RCC), Lymphofollicular Hyperplasia, Pancreaticoduodenectomy, and Cardiac Ablation.

Her clinical research consists of co-authoring 112 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hepatic Ischemia.

Specialties
Radiology
Licenses
Diagnostic Radiology in MA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

MD Anderson
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
Other Locations
MD Anderson
2240 Gulf Fwy S, Utmb Health League City Ho, League City, TX 77573
MD Anderson
13900 Katy Fwy, Houston, TX 77079

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology
Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology
Enrollment Status: Withdrawn
Publish Date: September 30, 2025
Intervention Type: Device
Study Phase: Phase 2
A Multicenter Phase I/II Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel With or Without NPC-1C in Patients With Metastatic or Locally Advanced Pancreatic Cancer Previously Treated With FOLFIRINOX
A Multicenter Phase I/II Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel With or Without NPC-1C in Patients With Metastatic or Locally Advanced Pancreatic Cancer Previously Treated With FOLFIRINOX
Enrollment Status: Terminated
Publish Date: May 07, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

110 Total Publications

Cervical Cancer Reporting Lexicon: A Collaboration by the SAR Uterine and Ovarian Cancer DFP, ESUR Female Pelvic Imaging Working Group, and Asian Society of Abdominal Radiology.
Cervical Cancer Reporting Lexicon: A Collaboration by the SAR Uterine and Ovarian Cancer DFP, ESUR Female Pelvic Imaging Working Group, and Asian Society of Abdominal Radiology.
Journal: AJR. American journal of roentgenology
Published: June 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Venkatesan's expertise for a condition
ConditionClose
      View All 33 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile